Discover

OMCL
Omnicell, Inc.
36.75
1 x 36.73
1 x 36.77
bid
ask
-
0.56
1.50%
01:27 PM
timesize
Ytd-18.87%
1y19.20%
36.71
day range
37.75
29.06
52 week range
55.00
Open37.30Prev Close37.31Low36.71High37.75Mkt Cap1.67B
Vol149.23KAvg Vol722.49KEPS1.91P/E19.24Forward P/E17.61
Beta0.98Short Ratio4.73Inst. Own103.91%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-3050-d Avg41.24200-d Avg40.561yr Est57.86
Earning
DateForEstimateReportedSurprisesurprise %
2026-10-292026-090.43N/AN/AN/A
2026-07-302026-060.470.940.47101.07%
2026-04-282026-030.330.550.2266.67%
2026-02-052025-120.470.4-0.07-14.89%
2025-10-302025-090.360.510.1541.67%
2025-07-312025-060.310.450.1445.16%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-03Piper SandlerUpgradeOverweightOverweight
2026-07-31Wells FargoUpgradeOverweightOverweight
2026-07-31KeybancUpgradeOverweightOverweight
2026-04-29KeybancUpgradeOverweightOverweight
2026-04-23Wells FargoUpgradeOverweightOverweight
2026-02-06Piper SandlerUpgradeOverweightOverweight
Profile
Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Insider Holder
DateNameRelationQuantityDescription
2026-05-31BAUER JOANNE BDirector49.92KStock Award(Grant)
2025-03-06ETTA NCHACHAChief Financial Officer132.02KStock Award(Grant)
2026-07-14LIPPS RANDALL AChief Executive Officer0.00Sale
2026-05-17MANLEY COREY JOfficer112.78KSale
2026-06-30NJOKU NNAMDIPresident167.09KStock Award(Grant)
2026-03-31NUTT BRIAN HOfficer23.09KStock Award(Grant)
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Blackrock Inc.7.54M277.53M16.58%
2026-03-30Vanguard Portfolio Management LLC3.21M118.34M7.07%
2026-03-30Wellington Management Group, LLP2.71M99.65M5.95%
2026-03-30Dimensional Fund Advisors LP2.45M90.20M5.39%
2026-03-30Millennium Management Llc2.29M84.24M5.03%
2026-06-29State Street Corporation2.09M76.78M4.59%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29iShares Trust-iShares Core S&P Small-Cap ETF2.74M100.90M6.03%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.35M49.87M2.98%
2026-06-29iShares Trust-iShares Russell 2000 ETF1.20M44.07M2.63%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund995.18K36.63M2.19%
2026-05-30Delaware Group Equity Funds V-Nomura Small Cap Core Fund802.78K29.55M1.77%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund633.93K23.34M1.39%